Reporting owner · CIK 0001874962

Appelhans Dannielle

Visual SEC Form 4 history across 2 companies, 8 transactions and 2 filings.

DIRHALOZYME THERAPEUTICS, INC.
Open-market mix
Latest filingSep 02, 2026, 08:59 PM
Filings2Form 4 records
Buying$00 purchases
Selling$00 sales
Net value$0Buys minus sells
Companies24 securities
Most recentSep 01, 2026grant

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
No open-market purchases or sales in this history.

Net value flow

Buys minus sells

Feb 26
$0
Sep 26
$0

Transaction texture

Ownership and ticket size

Average P/S size—
Median P/S size—
Direct7
Indirect1
Sep 01, 2026grant

Filing-only signals

Deterministic matches in this insider's history

Derivative Transactionfiling-context4Direct Ownershipfiling-context5

Latest Form 4 facts

Quick context from source filings

Latest transaction

No latest transaction fact is available.

Latest buy

No open-market insider purchase is available.

Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

HALOHALOZYME THERAPEUTICS, INC.2 transactions · latest Sep 02, 2026, 08:59 PMGBIOGeneration Bio Co.6 transactions · latest Feb 09, 2026, 10:29 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
HALOAppelhans Dannielle
DIR
grant1.77k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
0.0%09/0209/01
HALOAppelhans Dannielle
DIR
grant1.16k$0A
Direct Ownership Large Holdings Increase
0.0%09/0209/01
GBIOAppelhans Dannielle
DIR
return6.00k—D
Derivative Transaction Direct Ownership
0.0%02/0902/09
GBIOAppelhans Dannielle
DIR
return2.50k—D
Derivative Transaction Direct Ownership
0.0%02/0902/09
GBIOAppelhans Dannielle
DIR
return3.84k—D
Derivative Transaction Direct Ownership
0.0%02/0902/09
GBIOAppelhans Dannielle
DIR
return3.00k—D
Derivative Transaction Direct Ownership
0.0%02/0902/09
GBIOAppelhans Dannielle
DIR
U736—U—0.0%02/0902/09
GBIOAppelhans Dannielle
DIR
U1.26k—U
Direct Ownership
0.0%02/0902/09

Appelhans Dannielle Insider Activity FAQ

SEC Form 4 context

Who is Appelhans Dannielle?

Appelhans Dannielle is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001874962.

Which companies has Appelhans Dannielle reported transactions for?

HALOZYME THERAPEUTICS, INC., Generation Bio Co.

When was Appelhans Dannielle's latest insider buy?

No open-market insider purchase is available for this period.

When was Appelhans Dannielle's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.